Weight Loss Medication
Wegovy® Weight Loss Programme in Dubai
Medically Supervised Semaglutide Treatment – UAE
If you are searching for Wegovy® in Dubai, it is important to understand that this is a prescription-only medication that must be used within a medically supervised programme.
At Allure Weightloss UAE, Wegovy® (semaglutide) is offered as part of our structured clinical weight management pathway, combining physician assessment, bariatric nurse monitoring, and dietitian-led support.
What Is Wegovy®?
Wegovy® is a GLP-1 receptor agonist (semaglutide) prescribed for chronic weight management in adults who meet medical eligibility criteria.
It works by influencing appetite regulation and helping reduce overall calorie intake when combined with lifestyle changes.
Wegovy® is not suitable for everyone and can only be prescribed after doctor assessment.
Who May Be Eligible in Dubai?
You may be considered for Wegovy® if you:
- Have a BMI of 30 or above
- OR have a BMI of 27+ with weight-related health conditions
- Long-term Weight Management
All patients require:
- Medical History Review
- Safety screening
- Doctor consultation
Prescription is issued only if clinically appropriate.
Expected Progress with Wegovy®
Individual results vary. Clinical studies of semaglutide have demonstrated meaningful weight reduction when combined with structured lifestyle support.
At Allure Weightloss, we focus on:
- Safe Progress
- Sustainable Habits
- Long-term Weight Management
Not short-term solutions.
How Wegovy® Treatment Works
Wegovy® is administered once weekly via subcutaneous injection.
The dose is gradually increased over several months to improve tolerability.
Your prescribing doctor will adjust your schedule based on your clinical response
Patients typically use Wegovy for 68 weeks (16 months) or longer, depending on their weight loss goals and progress.
Our Medically Supervised Wegovy® Programmes
Unlike pharmacy-only access, our Dubai programmes provide the tiers below to ensure treatment, at the minimum, is used safetly and effectively :
Wegovy Core
Essential Support
- Obesity Dr Consultation
- Wegovy Medication Pen
- Monthly Bariatric Nurse Review
- 1 x Dietitian Assessment + Review
- Ongoing Nurse Symton Management
- Blood test at 3 months
- Body Fat Composition Scales
- Free 1 year membership to Nutracheck
Wegovy Support
Advanced Support
- Obesity Dr Consultation
- Wegovy Medication Pen
- Monthly Bariatric Nurse Review
- 3 x Dietitian Assessments + Review
- Ongoing Nurse Symton Management
- Blood test at 3 months
- Body Fat Composition Scales
- Free 1 year membership to Nutracheck
Wegovy Premium
Premium Support
- Obesity Doctor Consultation
- Wegovy Medication Pen
- Monthly Bariatric Nurse Review
- 6 x Dietitian Assessment + Review
- Ongoing Nurse Sypmtom Management
- Blood Test at 3 months
- Body Fat Composition Scales
- Free 1 year membership to Nutracheck
Why Choose Allure Weight Loss?
Comprehensive Care
Weight Loss injections combined with expert dietetic and bariatric nurse support as standard with all our Medication packages.
Personalized Plans
Tailored weight loss programs to meet your unique needs.
Long-Term Success
Focus on sustainable habits and lifestyle changes for lasting results.
Book Your Wegovy® Consultation in Dubai
If you are considering Wegovy® treatment in the UAE, the first step is a structured clinical assessment.
Book your consultation today to determine whether Wegovy® is appropriate for you.
Wegovy FAQs
Wegovy (semaglutide) is an FDA-approved prescription medication for chronic weight management in adults with obesity or overweight individuals with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or high cholesterol). It is a once-weekly injectable medication that helps with weight loss by reducing appetite
Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the GLP-1 hormone, which regulates appetite and food intake, leading to reduced hunger and calorie consumption, making it an effective weight loss treatment.
Wegovy is administered as a subcutaneous (under-the-skin) injection once a week. It is typically injected into the abdomen, thigh, or upper arm.
Wegovy is started at a low dose and gradually increased to minimize side effects. The typical dosing schedule is:
Week 1-4: 0.25 mg once weekly
Week 5-8: 0.5 mg once weekly
Week 9-12: 1 mg once weekly
Week 13-16: 1.7 mg once weekly
Week 17 and onward: 2.4 mg once weekly (maintenance dose)
Common side effects include:
Nausea
Vomiting
Diarrhea
Constipation
Stomach pain
Fatigue
Serious side effects, though rare, may include:
Pancreatitis
Gallbladder issues (e.g., gallstones)
Kidney problems
Increased heart rate
Thyroid tumors (based on animal studies, though human risk is unclear)
In clinical trials, Wegovy users lost an average of 15% of their body weight over 68 weeks when combined with a healthy diet and exercise.
A healthy, reduced-calorie diet with balanced macronutrients is recommended to enhance weight loss and minimize gastrointestinal side effects
Yes, regular physical activity is encouraged to maximize Wegovy’s benefits and support long-term weight management.
Wegovy should not be combined with other GLP-1 receptor agonists or weight loss medications without consulting a healthcare provider.
Potential interactions include:
Insulin or sulfonylureas (risk of low blood sugar)
Oral medications (delayed absorption due to slowed digestion)
Wegovy is not recommended for:
Individuals with a personal or family history of medullary thyroid carcinoma (MTC)
Those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Pregnant or breastfeeding women
Individuals with a history of severe pancreatitis
The cost of Wegovy varies depending on individual circumstances and chosen packages.
Alcohol should be consumed in moderation, as it may worsen gastrointestinal side effects and impact blood sugar levels.
Most users begin noticing weight loss within the first few weeks, with significant results over several months of consistent use.